Form 4: Karyopharm Therapeutics Executive Reshma Rangwala Sells Shares to Cover Tax Obligations

Reshma Rangwala, EVP & Chief Medical Officer of Karyopharm Therapeutics, sold 6,789 shares of common stock on April 22, 2024, to cover withholding tax liabilities.

Summary

• Reshma Rangwala, an executive at Karyopharm Therapeutics Inc., sold 6,789 shares of the company's common stock on April 22, 2024.
• The sale was executed at a price of $1.17 per share.
• The transaction was conducted under a pre-arranged automatic sale plan adopted on April 4, 2022.
• The purpose of the sale was to cover withholding tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Rangwala directly owns 342,931 shares of Karyopharm Therapeutics Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations are a routine part of executive compensation, particularly when dealing with equity-based compensation like restricted stock units. This type of transaction is generally viewed as a neutral event and doesn't necessarily reflect a change in the executive's long-term outlook on the company.

Key Dates